• 1
    Khanna, K. M., Lepisto, A. J., Decman, V. and Hendricks, R. L., Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 2004. 16: 463469.
  • 2
    Hull, H. F., Blumhagen, J. D., Benjamin, D. and Corey, L., Herpes simplex viral pneumonitis in childhood. J. Pediatr. 1984. 104: 211215.
  • 3
    Smyth, R. L., Higenbottam, T. W., Scott, J. P., Wreghitt, T. G., Stewart, S., Clelland, C. A., McGoldrick, J. P. and Wallwork, J., Herpes simplex virus infection in heart-lung transplant recipients. Transplantation 1990. 49: 735739.
  • 4
    Schuller, D., Spessert, C., Fraser, V. J. and Goodenberger, D. M., Herpes simplex virus from respiratory tract secretions: Epidemiology, clinical characteristics, and outcome in immunocompromised and nonimmunocompromised hosts. Am. J. Med. 1993. 94: 2933.
  • 5
    Tuxen, D. V., Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with adult respiratory distress syndrome. Chest 1994. 106: 28S–33S.
  • 6
    Camazine, B., Antkowiak, J. G., Nava, M. E., Lipman, B. J. and Takita, H., Herpes simplex viral pneumonia in the postthoracotomy patient. Chest 1995. 108: 876879.
  • 7
    van den Brink, J. W., Simoons-Smit, A. M., Beishuizen, A., Girbes, A. R., Strack van Schijndel, R. J. and Groeneveld, A. B., Respiratory herpes simplex virus type 1 infection/colonisation in the critically ill: Marker or mediator? J. Clin. Virol. 2004. 30: 6872.
  • 8
    Whitley, R. J., Viral encephalitis. N. Engl. J. Med. 1990. 323: 242250.
  • 9
    Adler, H., Beland, J. L., Del-Pan, N. C., Kobzik, L., Brewer, J. P., Martin, T. R. and Rimm, I. J., Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J. Exp. Med. 1997. 185: 15331540.
  • 10
    Adler, H., Beland, J. L., Del-Pan, N. C., Kobzik, L., Sobel, R. A. and Rimm, I. J., In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J. Neuroimmunol. 1999. 93: 208213.
  • 11
    Sciammas, R., Kodukula, P., Tang, Q., Hendricks, R. L. and Bluestone, J. A., T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 1997. 185: 19691975.
  • 12
    Inoue, T., Inoue, Y., Kosaki, R., Inoue, Y., Nishida, K., Shimomura, Y., Tano, Y. and Hayashi, K., Immunohistological study of infiltrated cells and cytokines in murine herpetic keratitis. Acta Ophthalmol. Scand. 2001. 79: 484487.
  • 13
    Grubor-Bauk, B., Simmons, A., Mayrhofer, G. and Speck, P. G., Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J. Immunol. 2003. 170: 14301434.
  • 14
    Stumpf, T. H., Case, R., Shimeld, C., Easty, D. L. and Hill, T. J., Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J. Gen. Virol. 2002. 83: 15791590.
  • 15
    Watanabe, D., Adachi, A., Tomita, Y., Yamamoto, M., Kobayashi, M. and Nishiyama, Y., The role of polymorphonuclear leukocyte infiltration in herpes simplex virus infection of murine skin. Arch. Dermatol. Res. 1999. 291: 2836.
  • 16
    Tumpey, T. M., Chen, S. H., Oakes, J. E. and Lausch, R. N., Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 1996. 70: 898904.
  • 17
    Shimeld, C., Whiteland, J. L., Nicholls, S. M., Grinfeld, E., Easty, D. L., Gao, H. and Hill, T. J., Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 1995. 61: 716.
  • 18
    Trapani, J. A. and Smyth, M. J., Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2002. 2: 735747.
  • 19
    Geiger, K. D., Gurushanthaiah, D., Howes, E. L., Lewandowski, G. A., Reed, J. C., Bloom, F. E. and Sarvetnick, N. E., Cytokine-mediated survival from lethal herpes simplex virus infection: Role of programmed neuronal death. Proc. Natl. Acad. Sci. USA 1995. 92: 34113415.
  • 20
    Geiger, K. D., Nash, T. C., Sawyer, S., Krahl, T., Patstone, G., Reed, J. C., Krajewski, S. et al., Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. Virology 1997. 238: 189197.
  • 21
    Cantin, E., Tanamachi, B. and Openshaw, H., Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 1999. 73: 34183423.
  • 22
    Cantin, E., Tanamachi, B., Openshaw, H., Mann, J. and Clarke, K., Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice. J. Virol. 1999. 73: 51965200.
  • 23
    Liu, T., Khanna, K. M., Carriere, B. N. and Hendricks, R. L., Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 2001. 75: 1117811184.
  • 24
    Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmire, J. K., Walsh, C. M. et al., A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 1999. 73: 25272536.
  • 25
    Chang, E., Galle, L., Maggs, D., Estes, D. M. and Mitchell, W. J., Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice. J. Virol. 2000. 74: 1183211840.
  • 26
    Schiff, D. and Rosenblum, M. K., Herpes simplex encephalitis (HSE) and the immunocompromised: A clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum. Pathol. 1998. 29: 215222.
  • 27
    Ghiasi, H., Perng, G., Nesburn, A. B. and Wechsler, S. L., Either a CD4(+) or CD8(+) T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microb. Pathog. 1999. 27: 387394.
  • 28
    Jones, C. M., Cose, S. C., Coles, R. M., Winterhalter, A. C., Brooks, A. G. et al., Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J. Virol. 2000. 74: 24142419.
  • 29
    Coles, R. M., Mueller, S. N., Heath, W. R., Carbone, F. R. and Brooks, A. G., Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 2002. 168: 834838.